12 Health Care Stocks Moving In Friday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's pre-market session, health care stocks showed significant movement. Ainos, Psyence Biomedical, and Mira Pharmaceuticals were among the top gainers, with Ainos leading at a 144.6% increase. On the downside, Amylyx Pharma experienced a significant drop of 81.5%. Other notable movers include Viracta Therapeutics with a 17.18% increase following their Q4 earnings report, and ALX Oncology Holdings, which fell 10.41% also after their Q4 earnings.
March 08, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
ALX Oncology Holdings fell 10.41% to $14.55 after their Q4 earnings, with a market cap of $724.8 million.
Negative market reaction to Q4 earnings indicates concerns among investors, possibly leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Amylyx Pharma's stock declined by 81.5% to $3.5, with a market cap of $237.2 million.
The steep decline in Amylyx Pharma's stock price could lead to a negative investor sentiment, potentially causing further short-term declines.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100
POSITIVE IMPACT
Ainos shares surged 144.6% to $2.74, with a market cap of $12.8 million.
The significant surge in Ainos's stock price could attract more investors, potentially leading to a short-term price increase.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Viracta Therapeutics stock increased by 17.18% to $0.95 following their Q4 earnings report, with a market cap of $36.6 million.
Positive reaction to the Q4 earnings report suggests investor confidence, likely leading to a short-term uptrend.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90